Investigational Runcaciguat Reduces Albuminuria in Patients With Chronic Kidney Disease, Diabetes: Presented at ERA/EDTA

    Press/Media: Expert CommentPopular

    Period19-Jun-2023

    Media contributions

    1

    Media contributions

    • TitleInvestigational Runcaciguat Reduces Albuminuria in Patients With Chronic Kidney Disease, Diabetes: Presented at ERA/EDTA
      Degree of recognitionInternational
      Media name/outletFirstWord Pharma
      Media typeWeb
      Date19/06/2023
      URLhttps://firstwordpharma.com/story/5752709
      PersonsRon Gansevoort